text: SARS CoV 2 infection and paediatric endocrine disorders Risks and management considerations Coronavirus 19 COVID 19 is a disease caused by the SARS CoV 2 virus the seventh coronavirus identified as causing disease in humans The SARS CoV 2 virus has multiple potential pathophysiologic interconnections with endocrine systems potentially causing disturbances in glucose metabolism hypothalamic and pituitary function adrenal function and mineral metabolism A growing body of data is revealing both the effects of underlying endocrine disorders on COVID 19 disease outcome and the effects of the SARS CoV 2 virus on endocrine systems However comprehensive assessment of the relationship to endocrine disorders in children has been lacking In this review we present the effects of SARS CoV 2 infection on endocrine systems and review the current literature on complications of COVID 19 disease in underlying paediatric endocrine disorders We provide recommendations on management of endocrinopathies related to SARS CoV 2 infection in this population With the surge in COVID 19 cases worldwide it is important for paediatric endocrinologists to be aware of the interaction of SARS CoV 2 with the endocrine system and management considerations for patients with underlying disorders who develop COVID 19 disease While children and adults share some risk factors that influence risk of complications in SARS CoV 2 infection it is becoming clear that responses in the paediatric population are distinct and outcomes from adult studies cannot be extrapolated Evidence emerging from paediatric studies provides some guidance but highlights the need for more research in this area 